Shares of Moderna, which last week announced positive early results for its coronavirus vaccine, have skyrocketed as much as 253% year-to-date, even though the company doesn't sell any products yet. It's now valued at more than $26 billion. If future studies go well, Moderna has said its vaccine could be available to the public as early as January. After spiking to as high as $87 on Monday, Moderna's stock price has since retreated below $70 as medical experts have concluded the company did not release enough information to know how significant the Phase 1 findings are. Moderna's chief medical officer and financial officer sold their stocks. Even though it is legal, some experts thought that the optics are terrible because it shows a lack of confidence in your company going forward.
If you were an investor, what factors would you take into considerations when investing in Moderna?
If the vaccine could be approved by FDA, how would you help Moderna commercialize the product?
Moderna unveiled encouraging coronavirus vaccine results. Then top execs dumped nearly $30 million of stock (CNN)